Holen Sie sich die Stockscreener-App
549.90
0.75%
4.07
Handel nachbörslich:
552.95
3.05
+0.55%
Schlusskurs vom Vortag:
$545.83
Offen:
$546.885
24-Stunden-Volumen:
13.18M
Relative Volume:
0.74
Marktkapitalisierung:
$1.40T
Einnahmen:
$214.96B
Nettoeinkommen (Verlust:
$70.59B
KGV:
19.99
EPS:
27.5066
Netto-Cashflow:
$48.25B
1W Leistung:
-6.77%
1M Leistung:
-14.59%
6M Leistung:
-16.13%
1J Leistung:
-25.60%
1-Tages-Spanne:
$543.23
$553.87
1-Wochen-Bereich:
$537.27
$590.24
52-Wochen-Spanne:
$520.26
$790.80
Meta Platforms Inc Stock (META) Company Profile
Firmenname
Meta Platforms Inc
Sektor
Telefon
650-543-4800
Adresse
1 META WAY, MENLO PARK
Compare META vs GOOGL, GOOG, SPOT, DASH
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
META
Meta Platforms Inc
|
549.90 | 1.39T | 214.96B | 70.59B | 48.25B | 27.51 |
GOOGL
Alphabet Inc
|
344.82 | 4.17T | 446.32B | 244.21B | 53.27B | 19.91 |
GOOG
Alphabet Inc
|
341.75 | 4.14T | 446.32B | 244.21B | 53.27B | 19.91 |
SPOT
Spotify Technology Sa
|
533.72 | 109.60B | 20.32B | 3.16B | 3.82B | 12.55 |
DASH
Doordash Inc
|
223.49 | 96.35B | 14.72B | 923.00M | 1.75B | 2.0994 |
Meta Platforms Inc Stock (META) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-07-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-07-16 | Fortgesetzt | Wedbush | Neutral |
| 2026-07-10 | Bestätigt | Citizens | Mkt Outperform |
| 2026-07-07 | Hochstufung | Erste Group | Hold → Buy |
| 2026-06-02 | Hochstufung | Arete | Neutral → Buy |
| 2026-05-20 | Bestätigt | Wells Fargo | Overweight |
| 2026-05-05 | Bestätigt | Mizuho | Outperform |
| 2026-04-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2026-04-10 | Bestätigt | Wolfe Research | Outperform |
| 2026-04-09 | Bestätigt | Rosenblatt | Buy |
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-03-30 | Bestätigt | Morgan Stanley | Overweight |
| 2026-03-05 | Herabstufung | Arete | Buy → Neutral |
| 2026-03-05 | Hochstufung | Erste Group | Hold → Buy |
| 2026-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Canaccord Genuity | Buy |
| 2026-01-29 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-29 | Bestätigt | Deutsche Bank | Buy |
| 2026-01-29 | Bestätigt | Evercore ISI | Outperform |
| 2026-01-29 | Bestätigt | Guggenheim | Buy |
| 2026-01-29 | Bestätigt | JP Morgan | Overweight |
| 2026-01-29 | Bestätigt | Jefferies | Buy |
| 2026-01-29 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-29 | Bestätigt | Mizuho | Outperform |
| 2026-01-29 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2026-01-29 | Bestätigt | Morgan Stanley | Overweight |
| 2026-01-29 | Bestätigt | Piper Sandler | Overweight |
| 2026-01-29 | Bestätigt | Pivotal Research Group | Buy |
| 2026-01-29 | Bestätigt | Robert W. Baird | Outperform |
| 2026-01-29 | Bestätigt | Roth Capital | Buy |
| 2026-01-29 | Bestätigt | Stifel | Buy |
| 2026-01-29 | Bestätigt | UBS | Buy |
| 2026-01-29 | Bestätigt | Wedbush | Outperform |
| 2026-01-29 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-29 | Bestätigt | Wolfe Research | Outperform |
| 2026-01-26 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2026-01-26 | Bestätigt | Raymond James | Strong Buy |
| 2026-01-26 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2026-01-23 | Bestätigt | Stifel | Buy |
| 2026-01-13 | Bestätigt | TD Cowen | Buy |
| 2026-01-12 | Bestätigt | Wells Fargo | Overweight |
| 2026-01-08 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2026-01-08 | Bestätigt | Guggenheim | Buy |
| 2025-12-04 | Hochstufung | Arete | Neutral → Buy |
| 2025-11-24 | Eingeleitet | BNP Paribas Exane | Outperform |
| 2025-11-10 | Herabstufung | Erste Group | Buy → Hold |
| 2025-10-30 | Bestätigt | Barclays | Overweight |
| 2025-10-30 | Bestätigt | Bernstein | Outperform |
| 2025-10-30 | Bestätigt | BofA Securities | Buy |
| 2025-10-30 | Bestätigt | Citigroup | Buy |
| 2025-10-30 | Bestätigt | JP Morgan | Overweight |
| 2025-10-30 | Bestätigt | Jefferies | Buy |
| 2025-10-30 | Bestätigt | Mizuho | Outperform |
| 2025-10-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-10-30 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-10-30 | Bestätigt | Piper Sandler | Overweight |
| 2025-10-30 | Bestätigt | Stifel | Buy |
| 2025-10-30 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2025-10-20 | Bestätigt | Oppenheimer | Outperform |
| 2025-10-07 | Bestätigt | Wells Fargo | Overweight |
| 2025-09-30 | Eingeleitet | Mizuho | Outperform |
| 2025-07-31 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-07-31 | Bestätigt | Bernstein | Outperform |
| 2025-07-31 | Bestätigt | BofA Securities | Buy |
| 2025-07-31 | Bestätigt | Citigroup | Buy |
| 2025-07-31 | Bestätigt | Citizens JMP | Mkt Outperform |
| 2025-07-31 | Bestätigt | JP Morgan | Overweight |
| 2025-07-31 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-07-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-07-31 | Bestätigt | Morgan Stanley | Overweight |
| 2025-07-31 | Bestätigt | Oppenheimer | Outperform |
| 2025-07-31 | Bestätigt | Pivotal Research Group | Buy |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-31 | Bestätigt | UBS | Buy |
| 2025-07-31 | Bestätigt | Wedbush | Outperform |
| 2025-07-31 | Bestätigt | Wells Fargo | Overweight |
| 2025-07-28 | Bestätigt | Guggenheim | Buy |
| 2025-07-16 | Bestätigt | Canaccord Genuity | Buy |
| 2025-07-03 | Hochstufung | Needham | Underperform → Hold |
| 2025-06-26 | Bestätigt | UBS | Buy |
| 2025-06-24 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | BofA Securities | Buy |
| 2025-05-01 | Bestätigt | Citigroup | Buy |
| 2025-05-01 | Bestätigt | Evercore ISI | Outperform |
| 2025-05-01 | Bestätigt | Goldman | Buy |
| 2025-05-01 | Bestätigt | Guggenheim | Buy |
| 2025-05-01 | Bestätigt | JP Morgan | Overweight |
| 2025-05-01 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2025-05-01 | Bestätigt | MoffettNathanson | Buy |
| 2025-05-01 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2025-05-01 | Bestätigt | Morgan Stanley | Overweight |
| 2025-05-01 | Bestätigt | Oppenheimer | Outperform |
| 2025-05-01 | Bestätigt | Piper Sandler | Overweight |
| 2025-05-01 | Bestätigt | Pivotal Research Group | Buy |
| 2025-05-01 | Bestätigt | Raymond James | Strong Buy |
| 2025-05-01 | Bestätigt | Rosenblatt | Buy |
| 2025-05-01 | Bestätigt | Roth Capital | Buy |
| 2025-05-01 | Bestätigt | Stifel | Buy |
| 2025-05-01 | Bestätigt | Truist | Buy |
| 2025-05-01 | Bestätigt | UBS | Buy |
| 2025-05-01 | Bestätigt | Wedbush | Outperform |
| 2025-04-14 | Bestätigt | Citigroup | Buy |
| 2025-04-10 | Bestätigt | Piper Sandler | Overweight |
| 2025-01-30 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2025-01-23 | Bestätigt | BofA Securities | Buy |
| 2025-01-22 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2025-01-06 | Bestätigt | Jefferies | Buy |
| 2025-01-03 | Bestätigt | Wolfe Research | Outperform |
| 2024-10-31 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-10-31 | Bestätigt | Pivotal Research Group | Buy |
| 2024-10-11 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-09 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2024-10-01 | Eingeleitet | Pivotal Research Group | Buy |
| 2024-09-30 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-09-10 | Eingeleitet | DA Davidson | Buy |
| 2024-09-05 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-01 | Bestätigt | BofA Securities | Buy |
| 2024-07-19 | Bestätigt | Oppenheimer | Outperform |
| 2024-07-16 | Eingeleitet | Wolfe Research | Outperform |
| 2024-07-10 | Bestätigt | TD Cowen | Buy |
| 2024-07-08 | Bestätigt | Wells Fargo | Overweight |
| 2024-07-01 | Bestätigt | Raymond James | Strong Buy |
| 2024-06-12 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-05-02 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2024-04-25 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-15 | Bestätigt | Citigroup | Buy |
| 2024-04-11 | Bestätigt | Piper Sandler | Overweight |
| 2024-04-08 | Bestätigt | Oppenheimer | Outperform |
| 2024-04-04 | Bestätigt | Jefferies | Buy |
| 2024-02-02 | Bestätigt | Guggenheim | Buy |
| 2024-02-02 | Bestätigt | JMP Securities | Mkt Outperform |
| 2024-02-02 | Bestätigt | JP Morgan | Overweight |
| 2024-02-02 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2024-02-02 | Bestätigt | Mizuho | Buy |
| 2024-02-02 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2024-02-02 | Bestätigt | Morgan Stanley | Overweight |
| 2024-02-02 | Bestätigt | Oppenheimer | Outperform |
| 2024-02-02 | Bestätigt | Piper Sandler | Overweight |
| 2024-02-02 | Bestätigt | ROTH MKM | Buy |
| 2024-02-02 | Bestätigt | Raymond James | Strong Buy |
| 2024-02-02 | Bestätigt | Robert W. Baird | Outperform |
| 2024-02-02 | Bestätigt | Seaport Research Partners | Buy |
| 2024-02-02 | Bestätigt | Stifel | Buy |
| 2024-02-02 | Bestätigt | Susquehanna | Positive |
| 2024-02-02 | Bestätigt | TD Cowen | Outperform |
| 2024-02-02 | Bestätigt | UBS | Buy |
| 2024-02-02 | Bestätigt | Wedbush | Outperform |
| 2024-02-02 | Bestätigt | Wells Fargo | Overweight |
| 2024-02-02 | Bestätigt | Wolfe Research | Outperform |
| 2024-01-23 | Bestätigt | Citigroup | Buy |
| 2024-01-17 | Bestätigt | Piper Sandler | Overweight |
| 2024-01-17 | Bestätigt | Wells Fargo | Overweight |
| 2024-01-09 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2023-12-20 | Fortgesetzt | Raymond James | Strong Buy |
| 2023-10-24 | Eingeleitet | Seaport Research Partners | Buy |
| 2023-08-22 | Eingeleitet | Wedbush | Outperform |
| 2023-08-01 | Bestätigt | Argus | Buy |
| 2023-07-28 | Hochstufung | China Renaissance | Hold → Buy |
| 2023-07-27 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2023-07-27 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-07-25 | Bestätigt | Mizuho | Buy |
| 2023-07-25 | Hochstufung | New Street | Neutral → Buy |
| 2023-07-19 | Bestätigt | Jefferies | Buy |
| 2023-07-19 | Bestätigt | Truist | Buy |
| 2023-07-17 | Bestätigt | Credit Suisse | Outperform |
| 2023-07-17 | Bestätigt | Goldman | Buy |
| 2023-07-17 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-07-13 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-07-12 | Bestätigt | Deutsche Bank | Buy |
| 2023-06-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-05-15 | Hochstufung | Loop Capital | Hold → Buy |
| 2023-04-27 | Bestätigt | Credit Suisse | Outperform |
| 2023-04-27 | Bestätigt | Deutsche Bank | Buy |
| 2023-04-27 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-27 | Bestätigt | Goldman | Buy |
| 2023-04-27 | Bestätigt | Guggenheim | Buy |
| 2023-04-27 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-04-27 | Bestätigt | JP Morgan | Overweight |
| 2023-04-27 | Bestätigt | Mizuho | Buy |
| 2023-04-27 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2023-04-27 | Bestätigt | Morgan Stanley | Overweight |
| 2023-04-27 | Bestätigt | Oppenheimer | Outperform |
| 2023-04-27 | Bestätigt | Piper Sandler | Overweight |
| 2023-04-27 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-04-27 | Bestätigt | Raymond James | Outperform |
| 2023-04-27 | Bestätigt | Robert W. Baird | Outperform |
| 2023-04-27 | Bestätigt | Rosenblatt | Buy |
| 2023-04-27 | Bestätigt | Stifel | Buy |
| 2023-04-27 | Bestätigt | TD Cowen | Market Perform |
| 2023-04-27 | Bestätigt | Truist | Buy |
| 2023-04-27 | Bestätigt | Wolfe Research | Outperform |
Alle ansehen
Meta Platforms Inc Aktie (META) Neueste Nachrichten
Teen drops high-profile social media addiction lawsuit - The Hill
Neoclouds Shine in AI Build Out - The Motley Fool
First week of California Meta trial spotlights internal emails and whistleblowers - KRCR
Meta Tells DC Circ. To Reject FTC Appeal - Law360
Meta Platforms (META) Undercuts Anthropic and OpenAI on Price With New Coding Agent - Yahoo Finance
Meta Rises as Investors Look Beyond $200 Billion Trial Risk - Yahoo! Finance Canada
Meta Platforms (META) Pitches AI for Everyone While Apple (AAPL) Quietly Turns to China - Yahoo Finance
Woman covertly filmed by Meta AI smart glasses raises privacy and consent concerns: "I had no say" - CBS News
An endless scroll of lawsuits - Tech Brew
Meta Platforms, Inc. $META Shares Sold by B. Metzler seel. Sohn & Co. AG - MarketBeat
Inside The First Week Of Meta’s Social Media Addiction Trial - Addiction Center
Meta Platforms Stock Drops 17% YTD: Should You Buy, Sell or Hold it? - Yahoo Finance
Meta’s Big Reckoning Is Here - WIRED
Bernstein reiterates Meta stock rating on AI investment outlook By Investing.com - Investing.com
Meta (META) Quietly Became A Major AI Customer While Building Its Own API Business - Yahoo Finance Singapore
Now movie theaters are starting to ban Meta smart glasses too. Here’s why - Fast Company
READY, FIRE, AIM: Phil Weiser Goes Big, Against Meta - Pagosa Daily Post
No more doom scrolling or Instagram Stories? A Meta trial loss could end the social media we know - CNBC
‘She Died by Design’: Meta on Trial Over Child Safety - KQED
River Road Asset Management LLC Purchases 172,721 Shares of Meta Platforms, Inc. $META - MarketBeat
OFI Invest Asset Management Has $291.40 Million Stock Position in Meta Platforms, Inc. $META - MarketBeat
What we know about the Meta lawsuit so far, and how it could turn into a ‘Big Tobacco’ moment - The Globe and Mail
HM Payson & Co. Has $87.45 Million Position in Meta Platforms, Inc. $META - MarketBeat
Commonwealth of Pennsylvania Public School Empls Retrmt SYS Cuts Stock Position in Meta Platforms, Inc. $META - MarketBeat
Cidel Asset Management Inc. Grows Stock Position in Meta Platforms, Inc. $META - MarketBeat
Meta Platforms, Inc. $META Stock Position Lessened by Asio Capital LLC - MarketBeat
Archford Capital Strategies LLC Raises Holdings in Meta Platforms, Inc. $META - MarketBeat
Meta defends safety efforts, critics disagree - The Arkansas Democrat-Gazette
AXON CAPITAL LP's Meta Platforms Inc(META) Holding History - GuruFocus
Meta Thinks Outside The Box With Memory (NASDAQ:META) - Seeking Alpha
US Teen Drops Social Media Addiction Lawsuit Against Meta, Google Before Trial - NDTV
New Jersey teen drops social media addiction lawsuit against Meta, Google and Snap: report - KATV
U.S. teen drops lawsuit against Meta, Google and Snap ahead of trial - The Japan Times
29 US states are suing Meta. What might it mean for the rest of the world? - The Conversation
US teen drops lawsuit against Meta, Google and Snap ahead of trial - The Standard (HK)
The first week of testimony wraps in the federal child safety case against Meta - NPR
Meta’s Trial Could Change Instagram Even If the Company Wins - TipRanks
DW News. . Meta is in court defending against allegations that it made its social media platforms Instagram and Facebook deliberately addictive. The company says social media addiction does not exist. Can social media be non-addictive? And if it were, would - facebook.com
Meta defends child safety record amid social media addiction allegations - KRCR
Top Meta Reporter: Zuckerberg Dropped a Major Hint About Meta’s Next AI Breakthrough and Nobody's Paying Attention - 24/7 Wall St.
Testimony says Meta prioritized growth, kept 'don't ask, don't tell' on under-13 users - WBFF
Meta defends its child safety efforts but critics say the social media giant falls short - NBC Bay Area
Meta faces risks whether it wins or loses major social media trial - Yahoo Finance Singapore
Australia Hits Meta, Google With 2.5% News Levy - TradingView
Meta Stock Sinks 32%, but Analysts See a 38% Rebound - Yahoo Finance
Meta becomes major AI customer of Microsoft’s Azure cloudreport - Investing.com
Meta’s Trial Adds a Trillion-Dollar Risk to Its Struggling Stock - Bloomberg.com
Meta emerges as major Microsoft Azure AI customer - Yahoo Finance
Meta becomes one of Microsoft’s largest AI customers: report - Seeking Alpha
RDA Financial Network's Meta Platforms Inc(META) Holding History - GuruFocus
Finanzdaten der Meta Platforms Inc-Aktie (META)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
0.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):